PET imaging technique does not improve outcomes in esophageal cancer patients

Patients with cancer of the esophagus—also known as the gullet—are often given chemo- or radiotherapy, with the aim of shrinking the tumor before it is surgically removed. Increasingly positron emission tomography (PET) is being used to monitor the size of the tumor during the treatment. To date, however, no benefit for patients has ensued. Read more.

Tags: Cancer PET Research

About NMC  |  Products  |  Quote  |  News  |  Resources  |  Contact  |  Sitemap